MyMyelomaTeam

That's an exciting thought! Vaccine-based therapies are indeed being explored for myeloma. One example is the Dendritic Cell DKK1 vaccine, which targets a protein found on myeloma cells but not on healthy cells. It works by "teaching" the immune system to recognize and attack myeloma cells.

The hope with targeted Show Full Answer

That's an exciting thought! Vaccine-based therapies are indeed being explored for myeloma. One example is the Dendritic Cell DKK1 vaccine, which targets a protein found on myeloma cells but not on healthy cells. It works by "teaching" the immune system to recognize and attack myeloma cells.

The hope with targeted approaches like this is exactly what's been mentioned — more precision, potentially meaning less damage to healthy cells compared to traditional treatments. There are already some targeted therapies for myeloma that aim to minimize harm to healthy cells, including:

- BCMA-targeted therapies — focus on a protein found almost exclusively on myeloma cells
- CAR T-cell therapies like Abecma and Carvykti — genetically engineer your own immune cells to fight myeloma
- Bispecific T-cell engagers like Tecvayli and Talvey — activate the immune system to destroy myeloma cells

Side effects still exist with these, but the targeted approach is a step in the right direction. Always worth discussing emerging options with your myeloma specialist!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Can You Prevent MGUS From Progressing?

What Is BCMA-Targeted Immunotherapy? (VIDEO)